This week, Certara said that Plexxikon has selected its D360 software solution to support data access and analysis for its drug discovery projects.
Certara said that scientists at Plexxikon are using the software to integrate project data and mine structure activity relationships using information from chemical registration and biological assay databases such as Accelrys’ Isentris and Assay Explorer.
The tool also lets users create their own queries and supports collaboration by providing an automated search and analysis workflow that can be shared with other researchers and reused. Furthermore, D360 enables biologists to assess the quality of screening data before they make it available to chemists for additional analysis.
The financial details of the agreement were not disclosed.